Mission statement

Arbe Announces Q3 2022 Financial Results

Retrieved on: 
Monday, November 14, 2022

TEL AVIV, Israel, Nov. 14, 2022 /PRNewswire/ -- Arbe Robotics Ltd. (Nasdaq: ARBE) ("Arbe"), a global leader in next-generation 4D Imaging Radar Solutions, today announced financial results for its third quarter ended September 30, 2022.

Key Points: 
  • TEL AVIV, Israel, Nov. 14, 2022 /PRNewswire/ -- Arbe Robotics Ltd. (Nasdaq: ARBE) ("Arbe"), a global leader in next-generation 4D Imaging Radar Solutions, today announced financial results for its third quarter ended September 30, 2022.
  • Net loss in Q3 2022 was $9.9 million, compared to a net loss of $13.3 million in Q3 2021.
  • The net loss in Q3 2022 included financial income of $1.0 million compared to $5.0 million of financial expenses in Q3 2021.
  • Arbe will host a live video webinar on Monday, Nov. 14 at 8:30 a.m. Eastern Time to discuss the company's third quarter 2022 financial results.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Schmitt Industries, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – SMIT

Retrieved on: 
Saturday, November 12, 2022

WHAT TO DO NEXT: To join the Schmitt Industries class action, go to https://rosenlegal.com/submit-form/?case_id=8823 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Schmitt Industries class action, go to https://rosenlegal.com/submit-form/?case_id=8823 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, A TOP RANKED FIRM, Encourages Barclays PLC Investors to Secure Counsel Before Important November 22 Deadline in Securities Class Action – BCS

Retrieved on: 
Saturday, November 12, 2022

WHAT TO DO NEXT: To join the Barclays class action, go to https://rosenlegal.com/submit-form/?case_id=8877 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Barclays class action, go to https://rosenlegal.com/submit-form/?case_id=8877 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, November 12, 2022

The Company has two operating segments, commercial and government,with the latter primarily serving agencies in the U.S. federal government and non-U.S. governments.

Key Points: 
  • The Company has two operating segments, commercial and government,with the latter primarily serving agencies in the U.S. federal government and non-U.S. governments.
  • On May 9, 2022, Palantir issued a press release announcing its Q1 financial results and guidance for Q2.
  • For more information on the Barclays class action go to: https://bespc.com/cases/BCS
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Opendoor, Schmitt, Block and Twitter and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, November 12, 2022

Following the Merger, the Company has operated a digital platform for buying and selling residential real estate in the U.S.

Key Points: 
  • Following the Merger, the Company has operated a digital platform for buying and selling residential real estate in the U.S.
  • For more information on the Block class action go to: https://bespc.com/cases/SQ
    On May 13, 2022, Elon Musk tweeted that a merger with Twitter was temporarily on hold.
  • For more information on the Twitter class action go to: https://bespc.com/cases/TWTR
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Dundee Corporation Announces Third Quarter 2022 Financial Results and Returns to Profit Through Successful Investments

Retrieved on: 
Friday, November 11, 2022

TORONTO, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the Corporation or Dundee) today announced its financial results for the three and nine months ended September 30, 2022.

Key Points: 
  • TORONTO, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the Corporation or Dundee) today announced its financial results for the three and nine months ended September 30, 2022.
  • Reported net income from investments for the third quarter of 2022 of $20.0 million (2021 loss of $41.0 million).
  • For the nine months ended September 30, 2022, the Corporation reported a net income from investments of $13.7 million (2021 loss of $50.5 million).
  • Dundee Technologies incurred a pre-tax loss of $0.9 million (2021 $0.8 million) during the three months ended September 30, 2022.

InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update

Retrieved on: 
Friday, November 11, 2022

VANCOUVER, British Columbia, Nov. 11, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (InMed or the Company) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results for the first quarter of fiscal year 2023, ended September 30, 2022.

Key Points: 
  • VANCOUVER, British Columbia, Nov. 11, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (InMed or the Company) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results for the first quarter of fiscal year 2023, ended September 30, 2022.
  • The Companys condensed financial statements and related MD&A for the first quarter of fiscal year 2023, ended September 30, 2022 will be available at www.inmedpharma.com and at www.sedar.com .
  • Enrollment and patient treatment in the Companys Phase 2 clinical trial, 755-201-EB, has continued through the first quarter and is expected to complete during calendar year 2022.
  • InMeds Phase 2 clinical trial now has all 11 clinical trial sites fully activated to screen and enroll patients.

Elah Holdings, Inc. Releases Third Quarter 2022 Report to Stockholders

Retrieved on: 
Friday, November 11, 2022

DALLAS, Nov. 11, 2022 /PRNewswire/ -- Elah Holdings, Inc. (OTC:ELLH) has released its interim unaudited financial statements and disclosure report for the third quarter of 2022. This report and additional company information can be found at www.elahholdings.com under the Financial Releases section of the website.

Key Points: 
  • DALLAS, Nov.11, 2022 /PRNewswire/ --Elah Holdings, Inc.(OTC:ELLH) has released its interim unaudited financial statements and disclosure report for the third quarter of 2022.
  • This report and additional company information can be found at www.elahholdings.comunder the Financial Releases section of the website.
  • For more information, visit www.elahholdings.com .
  • Elah Holdings' stock trades on the OTC Pink Market, which is operated by OTC Markets Group, a centralized electronic quotation service for over-the-counter securities under the symbol "ELLH."

Monarch Reports Its First Quarter Results

Retrieved on: 
Friday, November 11, 2022

Forward-looking statements are subject to known or unknown risks and uncertainties that may cause actual results to differ materially from those anticipated or implied in the forward-looking statements.

Key Points: 
  • Forward-looking statements are subject to known or unknown risks and uncertainties that may cause actual results to differ materially from those anticipated or implied in the forward-looking statements.
  • Many of these uncertainties and contingencies can directly or indirectly affect, and could cause, actual results to differ materially from those expressed or implied in any forward-looking statements.
  • There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.
  • Further information regarding the Corporation is available in the SEDAR database (www.sedar.com) and on the Corporations website at: www.monarchmining.com

NuScale Power Reports Third Quarter 2022 Results

Retrieved on: 
Friday, November 11, 2022

NuScale Power Corporation (NYSE: SMR), the industry-leading provider of proprietary and innovative advanced small modular reactor nuclear technology, today announced results for the third quarter ended September 30, 2022.

Key Points: 
  • NuScale Power Corporation (NYSE: SMR), the industry-leading provider of proprietary and innovative advanced small modular reactor nuclear technology, today announced results for the third quarter ended September 30, 2022.
  • NuScale will host a conference call Monday, November 14, 2022, at 8:30 a.m.
  • NuScale Power is poised to meet the diverse energy needs of customers across the world.
  • The groundbreaking NuScale Power Module (NPM), a small, safe pressurized water reactor, can generate 77 megawatts of electricity (MWe) and can be scaled to meet customer needs.